Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product

BACKGROUND: Botulism is a rare, serious, and sometimes fatal paralytic illness caused by exposure to neurotoxins produced by Clostridium botulinum bacteria. Patients with documented or suspected exposure to botulinum toxin serotypes A-G can be treated with BAT(®) [Botulism Antitoxin Heptavalent (A,...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Deborah M., Kumar, Veena R., Arper, Diana L., Kruger, Eliza, Bilir, S. Pinar, Richardson, Jason S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837762/
https://www.ncbi.nlm.nih.gov/pubmed/31697731
http://dx.doi.org/10.1371/journal.pone.0224700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837762/
https://www.ncbi.nlm.nih.gov/pubmed/31697731
http://dx.doi.org/10.1371/journal.pone.0224700

Ejemplares similares